Biofrontera Inc.

BFRIReported to SECin USCIK 0001858685Filings at SEC EDGAR

BFRI is one of 2 listed share classes under this CIK; the filings below cover all of them.

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

4
Form 4 lines at Biofrontera Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Luebbert HermannCEO & ChairmanOption exercisenothing paid62,500 sharesJul 29, 2026Luebbert HermannCEO & Chairmannothing paidExercise · Jul 29Option exercise62,500Jul 29, 2026
Luebbert HermannCEO & ChairmanOption exercise—62,500 sharesJul 29, 2026Luebbert HermannCEO & Chairman—Exercise · Jul 29Option exercise62,500Jul 29, 2026
Leffler Eugene FrederickChief Financial OfficerOption exercisenothing paid31,250 sharesJul 29, 2026Leffler Eugene FrederickChief Financial Officernothing paidExercise · Jul 29Option exercise31,250Jul 29, 2026
Leffler Eugene FrederickChief Financial OfficerOption exercise—31,250 sharesJul 29, 2026Leffler Eugene FrederickChief Financial Officer—Exercise · Jul 29Option exercise31,250Jul 29, 2026